201 related articles for article (PubMed ID: 30575174)
1. Long-term survival with stereotactic radiotherapy for imaging-diagnosed pituitary tumors in dogs.
Hansen KS; Zwingenberger AL; Théon AP; Kent MS
Vet Radiol Ultrasound; 2019 Mar; 60(2):219-232. PubMed ID: 30575174
[TBL] [Abstract][Full Text] [Related]
2. Effects of radiotherapy on pituitary corticotroph macrotumors in dogs: a retrospective study of 12 cases.
de Fornel P; Delisle F; Devauchelle P; Rosenberg D
Can Vet J; 2007 May; 48(5):481-6. PubMed ID: 17542365
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes and target delineation utilizing CT and MRI in 13 dogs treated with a uniform stereotactic radiation therapy protocol (16 Gy single fraction) for pituitary masses: (2014-2017).
Gieger TL; Nolan MW
Vet Comp Oncol; 2021 Mar; 19(1):17-24. PubMed ID: 32548944
[TBL] [Abstract][Full Text] [Related]
4. Single fraction stereotactic radiation therapy (stereotactic radiosurgery) is a feasible method for treating intracranial meningiomas in dogs.
Kelsey KL; Gieger TL; Nolan MW
Vet Radiol Ultrasound; 2018 Sep; 59(5):632-638. PubMed ID: 29873144
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cobalt 60 radiotherapy in dogs with pituitary-dependent hyperadrenocorticism.
Goossens MM; Feldman EC; Theon AP; Koblik PD
J Am Vet Med Assoc; 1998 Feb; 212(3):374-6. PubMed ID: 9470046
[TBL] [Abstract][Full Text] [Related]
6. Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs.
Théon AP; Feldman EC
J Am Vet Med Assoc; 1998 Jul; 213(2):225-31. PubMed ID: 9676592
[TBL] [Abstract][Full Text] [Related]
7. Effect of pituitary-dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas.
Rapastella S; Morabito S; Sharman M; Benoit J; Schiavo L; Morris J; Dobson JM; Scudder CJ
J Vet Intern Med; 2023; 37(4):1331-1340. PubMed ID: 37218395
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart-base tumours in dogs.
Hansen KS; Théon AP; Willcox JL; Stern JA; Kent MS
Vet Comp Oncol; 2021 Mar; 19(1):191-200. PubMed ID: 33135852
[TBL] [Abstract][Full Text] [Related]
9. Survival, neurologic response, and prognostic factors in dogs with pituitary masses treated with radiation therapy and untreated dogs.
Kent MS; Bommarito D; Feldman E; Theon AP
J Vet Intern Med; 2007; 21(5):1027-33. PubMed ID: 17939560
[TBL] [Abstract][Full Text] [Related]
10. COMPARISON OF TWO COARSE FRACTIONATED RADIATION PROTOCOLS FOR THE MANAGEMENT OF CANINE PITUITARY MACROTUMOR: AN OBSERVATIONAL STUDY OF 24 DOGS.
Marcinowska A; Warland J; Brearley M; Dobson J
Vet Radiol Ultrasound; 2015; 56(5):554-62. PubMed ID: 26129808
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases.
Kruckman-Gatesy CR; Ames MK; Griffin LR; Boss MK; Rao S; Leary D; LaRue SM
J Vet Cardiol; 2020 Feb; 27():62-77. PubMed ID: 32078943
[TBL] [Abstract][Full Text] [Related]
12. Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy.
Zwingenberger AL; Pollard RE; Taylor SL; Chen RX; Nunley J; Kent MS
J Vet Intern Med; 2016 May; 30(3):827-35. PubMed ID: 27149650
[TBL] [Abstract][Full Text] [Related]
13. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013-2016).
Gieger TL; Nolan MW
Vet Comp Oncol; 2018 Mar; 16(1):E68-E75. PubMed ID: 28741887
[TBL] [Abstract][Full Text] [Related]
14. Treatment of MRI-Diagnosed Trigeminal Peripheral Nerve Sheath Tumors by Stereotactic Radiotherapy in Dogs.
Hansen KS; Zwingenberger AL; Théon AP; Pfeiffer I; Kent MS
J Vet Intern Med; 2016 Jul; 30(4):1112-20. PubMed ID: 27279132
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of feline hyperadrenocorticism with pituitary macroadenoma using radiation therapy: a case study.
Yayoshi N; Hamamoto Y; Oda H; Haga A; Koyama K; Sako T; Mori A
J Vet Med Sci; 2022 Jul; 84(7):898-904. PubMed ID: 35527017
[TBL] [Abstract][Full Text] [Related]
16. Outcome of 9 dogs treated with stereotactic radiation therapy for primary or metastatic vertebral osteosarcoma.
Swift KE; LaRue SM
Vet Comp Oncol; 2018 Mar; 16(1):E152-E158. PubMed ID: 29181871
[TBL] [Abstract][Full Text] [Related]
17. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995).
Greco DS; Peterson ME; Davidson AP; Feldman EC; Komurek K
J Am Vet Med Assoc; 1999 May; 214(9):1349-53. PubMed ID: 10319177
[TBL] [Abstract][Full Text] [Related]
18. Clinical and imaging findings, treatments, and outcomes in 27 dogs with imaging diagnosed trigeminal nerve sheath tumors: A multi-center study.
Swift KE; McGrath S; Nolan MW; Young M; Reese M; Rao S; Randall E; Leary D; LaRue S
Vet Radiol Ultrasound; 2017 Nov; 58(6):679-689. PubMed ID: 28758278
[TBL] [Abstract][Full Text] [Related]
19. Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs.
Mariani CL; Schubert TA; House RA; Wong MA; Hopkins AL; Barnes Heller HL; Milner RJ; Lester NV; Lurie DM; Rajon DA; Friedman WA; Bova FJ
Vet Comp Oncol; 2015 Dec; 13(4):409-23. PubMed ID: 24007303
[TBL] [Abstract][Full Text] [Related]
20. Volumetric-modulated arc stereotactic radiotherapy for canine adrenocortical tumours with vascular invasion.
Dolera M; Malfassi L; Pavesi S; Finesso S; Sala M; Carrara N; Marcarini S; Mazza G; Bianchi C; Urso G
J Small Anim Pract; 2016 Dec; 57(12):710-717. PubMed ID: 27759159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
